Login to Your Account

For Moderate to Severe Vasomotor Symptoms

Ligand Scores on FDA Approval of Pfizer’s Hot Flash Drug Duavee

By Marie Powers
Staff Writer

Friday, October 4, 2013
Ligand Pharmaceuticals Inc. scored the first direct hit from its decades-long collaboration with Pfizer Inc. as the FDA approved Duavee (conjugated estrogens/bazedoxifene) in a once-daily 0.45-mg/20-mg tablet form.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription